glp-1 side effects risks 𝐆𝐋𝐏-𝟏 𝐖𝐞𝐢𝐠𝐡𝐭-𝐋𝐨𝐬𝐬 & 𝐃𝐢𝐚𝐛𝐞𝐭𝐞𝐬 𝐃𝐫𝐮𝐠𝐬 drugs are gaining popularity in India for treating diabetes and obesity — but they come with serious risks. ✓ Prescription-only — Can only be prescribed by These medications also come with

Study tracks weight regain after stopping medication The new study, led by researchers at the University of Oxford and published in The BMJ, reviewed 37 existing clinical trials involving 9,341 participants who had taken weight-loss medications

Phone Support Bad No phone support available

By 12 months post-stop, most patients have returned to within 10 to 20 percent of their starting weight

y l s kt hp c khuyn khch

Scope of the Report GLP-1 Diabetes Treatment Drugs Market by Segments Drug Type: Liraglutide Dulaglutide Exenatide Others Application: Online Pharmacy Hospital Clinic Region: North America United States Canada Mexico Europe Germany United Kingdom France Italy Spain Nordic BENELUX Rest of Europe East Asia China Japan South Korea South Asia & Pacific India ASEAN Australia & New Zealand Rest of South Asia & Pacific Latin America Brazil Chile Rest of Latin America Middle East & Africa Kingdom of Saudi Arabia Other GCC Countries Turkiye South Africa Other African Union Rest of Middle East & Africa Frequently Asked Questions How big is the GLP-1 diabetes treatment drugs market in 2025